NCT07110961 The Suggested Immobilization Test With Exploratory Heart Rate Variability Analysis for Diagnosis of Restless Legs Syndrome
| NCT ID | NCT07110961 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Siriraj Hospital |
| Condition | Restless Leg Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 52 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 52 participants in total. It began in 2025-10-01 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Restless leg syndrome (RLS) is not uncommon and can also affect people's health and quality of life. Mainly, RLS is diagnosed based on clinical criteria subjectively. Sometimes it is difficult to differentiate between RLS and mimickers, especially in patients with comorbidities such as diabetes or parkinson's disease. We believe that using objective tests would facilitate accuracy in RLS diagnosis, which leads to proper management of patients.
Eligibility Criteria
Inclusion Criteria: * Patients who were appointed for an in-lab polysomnographic study and fit the clinical diagnosis criteria for restless leg syndrome based on International Restless Legs Syndrome Study Group (IRLSSG) Exclusion Criteria: * Patient with physical limitations including stroke, dementia or hearing impairment * Pregnant women
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07110961 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Restless Leg Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07110961 currently recruiting?
Yes, NCT07110961 is actively recruiting participants. Contact the research team at jindapa.sri@mahidol.ac.th for enrollment information.
Where is the NCT07110961 trial being conducted?
This trial is being conducted at Bangkok, Thailand.
Who is sponsoring the NCT07110961 clinical trial?
NCT07110961 is sponsored by Siriraj Hospital. The trial plans to enroll 52 participants.